DR. JUI-LIEN CHOU, M.D.

Plain English
The study looked at how likely childhood cancer survivors are to die after being diagnosed with colorectal cancer that develops later, known as colorectal subsequent malignant neoplasms (CRC-SMN). Out of more than 25,600 survivors, 96 were diagnosed with CRC-SMN, with half of those cases occurring before age 40. The research found that these survivors were three times more likely to die from any cause after their diagnosis compared to those who did not develop CRC, highlighting the need for closer medical attention for these patients. Who this helps: This helps childhood cancer survivors and their doctors by emphasizing the importance of monitoring for colorectal cancer.

Plain English
This research focused on understanding the effects of mpox (formerly known as monkeypox) on pregnant women and their infants during an outbreak in the U.S. from August to December 2022. Out of 26 pregnant women studied, 19 had healthy babies, three delivered early, and four experienced pregnancy losses, while two infants were diagnosed with mpox shortly after birth. Importantly, all women who were treated with the antiviral drug tecovirimat reported no harmful side effects. Who this helps: This helps pregnant women and healthcare providers by providing important information on the safety of treating mpox during pregnancy.

Plain English
This study looked at the differences between using one or multiple blood vessel "perforators" in breast reconstruction surgery that uses tissue from the abdomen. Researchers analyzed data from 258 patients and found that using more perforators added about 27.6 minutes to the surgery time and increased hospital stays by about half a day. These additional perforators also raised the cost of the procedure by $4,591, although the risk of complications like flap loss or fat necrosis was similar for both methods. Who this helps: This research benefits patients undergoing breast reconstruction and their doctors by providing important information on surgical options.

Plain English
The ASHP Pharmacy Forecast 2026 looks at important trends that will affect hospitals and pharmacy practices in the coming years. A survey of 298 pharmacy leaders highlighted key areas of focus, such as rising drug costs and the need for better patient care, rating the likelihood of these issues affecting healthcare over the next five years. This information helps pharmacy departments strategically plan to address these challenges and improve services. Who this helps: This benefits pharmacy staff and hospital leaders who want to enhance patient care and adapt to changing healthcare needs.

Plain English
This study focused on improving the performance of zinc-air batteries by creating an effective method to produce certain atomic sites (FeN sites) that help with an important chemical reaction (oxygen reduction). Researchers found that by using oxalate ions, they could create a dense arrangement of these sites, leading to better battery performance, with specific metrics showing notably high efficiency in both acidic and alkaline conditions (0.79 V and 0.89 V, respectively) and a battery capacity of 781 mAh g. These advancements are significant because they can increase the effectiveness and lifespan of batteries, making them more useful for energy storage. Who this helps: Patients needing reliable energy solutions for medical devices and professionals working in battery technology.

Plain English
This study looked at how genes are expressed differently in the brains of men and women with Alzheimer's disease (AD). Researchers found that women had 77 genes that were not functioning correctly in their brains, while men had 49, meaning women might experience more severe symptoms. Understanding these differences can lead to better ways to diagnose and treat Alzheimer's for both men and women. Who this helps: This helps patients with Alzheimer's and their doctors.

Plain English
Researchers studied the impact of a new testing method for detecting methicillin-resistant Staphylococcus aureus (MRSA) infections in patients' noses, along with the involvement of pharmacists in managing treatments. They found that this approach led to a 20.2% decrease in the use of antibiotics specifically targeting MRSA across four hospitals and in 17 out of 23 patient care units. This is important because it helps reduce unnecessary antibiotic use, which can fight antibiotic resistance and improve patient safety. Who this helps: This helps patients by ensuring they receive appropriate treatments and reducing the risk of antibiotic-related complications.

Plain English
This study explored a new treatment approach for prostate cancer and multiple myeloma by using two therapies that target a protein called CD46. Researchers found that combining two treatments—an antibody-drug conjugate (ADC) and a radioactive agent—led to better results in fighting tumors, showing improved tumor control and survival rates in trials. Specifically, the combination therapy resulted in increased cell death and better tumor management compared to using either treatment alone, making it a promising method for more effective cancer care. Who this helps: This benefits patients with prostate cancer and multiple myeloma, offering them new treatment options.

Plain English
This study looked at how the size of the liver left after surgery (known as the future liver remnant volume or FLRV%) affects the risk of serious health problems after a liver surgery called hepatectomy, particularly liver failure. It involved 1,748 patients and found that if at least 30% of the liver remains healthy after surgery, the risk of severe complications drops significantly. Specifically, for every 10% increase in FLRV, the likelihood of severe liver failure-related complications decreased by about 40%. Who this helps: This information benefits patients undergoing liver surgery, as it helps determine safer surgical practices.

Plain English
This study developed a quick test to measure the activity of two types of interferons, which are proteins involved in inflammatory diseases. Researchers found that by examining certain markers (CD169 and CD274) in blood cells, they could reliably assess interferon levels in patients with conditions like macrophage activation syndrome and systemic lupus erythematosus. This is important because it provides a fast way to check for interferon abnormalities, which can help doctors tailor treatments for patients with inflammatory diseases. Who this helps: This benefits patients with inflammatory diseases and their doctors.

Plain English
This study looked at three new genetic changes in the DOCK2 gene that make some people more prone to viral infections. Researchers found these changes in six individuals aged 3 months to 50 years who had severe infections from viruses like HPV and COVID-19. The study shows that even small changes in this gene can weaken the immune system in otherwise healthy people, and it suggests that a specific type of therapy, weekly interferon treatment, can help improve their condition. Who this helps: This information is valuable for patients with unexplained viral infections and their doctors, as it helps identify a potential genetic cause and treatment.

Plain English
This study focused on improving how researchers identify genetic interactions in cells using a method called GRAPE. The researchers found that GRAPE was more accurate than existing methods, particularly for weaker genetic interactions, correctly identifying these interactions in simulation tests 85% of the time compared to only 70% for previous methods. This advancement is significant because it enhances the ability to discover new potential treatments for cancer by pinpointing specific genetic combinations that could be targeted. Who this helps: Patients with cancer and doctors seeking better treatment options.

Plain English
Researchers studied skin samples from 17 adults, including 11 with atopic dermatitis (AD), to better understand the immune and skin cell interactions involved in the condition. They identified over a quarter of a million cells and found that certain immune cells and signals were linked to problems with skin barrier function and T cell activity, which are associated with AD. This research reveals important cell types and interactions that may contribute to the inflammation seen in AD, potentially guiding better treatments. Who this helps: This helps patients with atopic dermatitis and their healthcare providers.

Plain English
Researchers studied a new type of immune cell called chimaeric antigen receptor macrophages (CARMA) to fight brain tumors caused by cancers like lung, melanoma, and breast cancer. They found that these CARMA cells can cross the protective barrier around the brain and significantly reduce the growth of brain metastases in lab mice. This is important because about 30% of patients with these cancers develop brain tumors, and treatments are often limited; CARMA may offer a new, effective option. Who this helps: Patients with brain metastases from cancers such as lung, melanoma, and breast cancer.

Plain English
This study looked at a surgical method called anterior ethmoid artery ligation (AEAL) to stop severe nosebleeds that don't respond to other treatments. Out of 122 patients treated with different methods of AEAL, about 7% experienced bleeding after surgery, and nearly 28% had some complications, mainly from one specific surgical technique. The findings show that AEAL can effectively control persistent nosebleeds, but there are potential side effects that patients should be aware of. Who this helps: This helps patients suffering from severe nosebleeds and their doctors in deciding treatment options.

Plain English
This study focused on improving solid-state lithium metal batteries, which are crucial for energy storage but often struggle to perform well at different temperatures. Researchers created a new type of battery electrolyte called PDPC, which combines different chemical groups to enhance the flow of ions and stability. The PDPC electrolyte demonstrated a high ionic conductivity of 1.8, improved efficiency, and can work effectively in temperatures ranging from -10 to 60 degrees Celsius, making these batteries safer and more reliable. Who this helps: This benefits battery manufacturers and consumers looking for more efficient and safer energy storage solutions.

Plain English
The study looked at how a protein called CD84 is linked to recovery from respiratory viral infections, specifically the avian influenza virus A(H7N9) and COVID-19. Researchers found that high levels of CD84 in patients recovering from A(H7N9) infection were associated with better outcomes, while low levels were seen in those who didn't survive. In mice infected with the influenza virus, higher CD84 levels in certain immune cells were linked to milder disease, showing that CD84 plays a role in fighting off these infections. Who this helps: This information helps patients suffering from respiratory viral infections and doctors treating them.

Plain English
This study looked at a protein called Src, commonly found in many types of cancer, and discovered that it can be flipped and sent to the cell surface in a unique way. Researchers found that this happens through a process called autophagolysosomal exocytosis, and they noticed that targeting the surface Src with specific antibodies can kill cancer cells in laboratory tests and mouse models. These findings are important because they offer a new way to attack cancer by using treatments that focus on this protein at the cell surface. Who this helps: This helps cancer patients who may benefit from new antibody therapies targeting Src.

Plain English
This study focuses on a protein called TGFBR3, which plays an important role in how cells respond to signals that regulate growth and development. The researchers found that TGFBR3 can influence many health issues, including cancer and heart disease, by acting in different ways depending on the context. Understanding TGFBR3 better could lead to new treatments and improve how we approach various diseases. Who this helps: This helps patients with cancer, heart disease, and other serious conditions.

Plain English
This research looked at how using electrical stimulation in combination with advanced nerve management techniques could help reduce pain in patients who have had amputations and are suffering from painful nerve issues. The study found that, after using a device for pain relief, patients' pain scores dropped significantly from an average of 8.5 to 2.0 out of 10 over six months, and their overall pain behaviors and interference with daily life improved as well. This matters because many amputees struggle with chronic pain, and this approach may provide a new, effective option for managing their discomfort. Who this helps: This benefits amputees dealing with chronic nerve pain.

Plain English
This study looked at how sarcopenia, or loss of muscle mass, affects older patients (aged 65 and up) undergoing autologous breast reconstruction surgery. It found that patients with sarcopenia experienced higher pain management needs, with an average increase in daily pain medication use from 22.9 to 35.9 mg, and greater blood loss during surgery. However, both sarcopenic and nonsarcopenic patients had similar complication rates and lengths of hospital stays, which means surgery is still safe for older patients. Who this helps: This information helps doctors and healthcare providers make better decisions for older patients considering this type of surgery.

Plain English
This research reviewed the use of a synthetic protein called rhBMP-2 as an alternative to traditional bone grafts for children needing facial surgeries. They found that rhBMP-2 can lead to shorter surgery times and hospital stays, and while some studies showed it works as well or better than the standard bone grafts for bone growth, the results varied—4 out of 12 studies favored rhBMP-2 for bone formation, while others showed no difference. Understanding these options is important because it can lead to less invasive procedures and better recovery for young patients needing facial reconstruction. Who this helps: This helps pediatric patients undergoing craniofacial surgery.

Plain English
This study examined two types of inherited eye diseases—ABCA4 and PRPH2 retinopathies—looking at their symptoms, eye tests, and genetic variations. Researchers analyzed data from 155 patients with ABCA4 retinopathy and 133 with PRPH2 retinopathy to find specific tests that could differentiate between the two conditions. They discovered that certain eye test results (like flicker and b-wave peak times) could reliably indicate which disease a patient has, with sensitivities as high as 93%, which is crucial for personalized treatment plans. Who this helps: This helps eye doctors and patients with inherited retinal diseases.

Plain English
This study looked at how reanalyzing genetic information can help diagnose rare diseases as patient symptoms change and scientific knowledge grows. The researchers at Boston Children's Hospital found that out of 42 patients' genetic test results reviewed, 33 showed strong links to diseases, and 3 were uncertain but possibly relevant. This is important because it shows that routine genomic reanalysis can lead to better diagnosis and treatment for patients with rare diseases. Who this helps: Patients with rare diseases and their doctors.

Plain English
This study focused on improving how we assess the quality of brain imaging data used in Precision Functional MRI (PFM), which looks at how the brain is organized. Researchers developed a new tool called the Network Similarity Index (NSI) that accurately measures the quality of brain connectivity patterns, and they found that NSI closely matched expert opinions on data usability. This is important because it helps researchers know when they have enough quality data for reliable results, ultimately enhancing brain research and its applications. Who this helps: This helps researchers and doctors working on brain-related studies and treatments.

Plain English
This study looked at how different methods analyze genetic tests that identify specific vulnerabilities in cancer cells, particularly when using CRISPR technology. Researchers found that the Z-score method (ZdLFC) consistently identified more accurate pairs of genes that could be targeted together to kill cancer cells compared to other methods, performing better without needing a prior data set for training. This matters because it could make it easier to find new cancer treatments by pinpointing which gene combinations can effectively target tumors. Who this helps: This benefits cancer researchers and developers of targeted therapies.

Plain English
This study examined why patients with a specific genetic condition known as XIAP deficiency do not develop lymphomas despite severe infections from the Epstein-Barr virus (EBV). They found that B cells from these patients were less likely to become transformed by EBV, showing a 70% lower transformation rate compared to healthy controls, and they died off more quickly when infected. This is significant because it reveals how XIAP helps prevent the progression from infection to lymphoma, offering insights that could improve understanding and treatment for certain patients with EBV infections. Who this helps: This helps patients with XIAP deficiency and their doctors.

Plain English
This study looked at how certain substances produced by our own bodies, called oxidized phospholipids (oxPLs), affect our immune response during infections. The researchers found that oxPLs increase inflammation in both mice and humans, which can be harmful, while not actually reducing the number of pathogens. Specifically, they discovered that oxPLs inhibit a protein that normally helps anti-inflammatory responses, leading to potential organ damage and even death. Who this helps: This helps patients at risk of severe inflammatory responses during infections.

Plain English
This study focused on the role of a protein called RAC1 in liver cancer (hepatocellular carcinoma) and how it affects the effectiveness of radiation therapy. Researchers found that RAC1 was highly active in liver cancer tissues, linked to worse outcomes for patients, and that when they blocked RAC1, it made the cancer cells more susceptible to radiation treatment. Specifically, when the RAC1 activity was inhibited using a drug, it improved the response to radiation by disrupting survival signals in cancer cells. Who this helps: This benefits patients with liver cancer by potentially improving their treatment outcomes.

Plain English
This study looked at two treatments for patients with liver cancer from colorectal tumors that cannot be surgically removed: Hepatic Artery Infusion chemotherapy (HAI) and Transarterial Radioembolization (TARE). Researchers found that patients receiving HAI after their first or second round of chemotherapy had a lower risk of dying compared to those receiving TARE; specifically, the risk of death was 46% higher for TARE patients after one-line treatment and 96% higher after two-line treatment. However, for patients who had already tried several other treatments, both therapies showed similar outcomes. Who this helps: This research is valuable for doctors and patients deciding between these two treatment options.

Plain English
This study looked at factors that affect how well surgical wounds heal after removing drainage tubes from the chest and abdomen. Researchers analyzed data from 420 patients and found seven key risk factors for poor healing, including low serum albumin levels and infection at the incision site. The predictive model created in this study, called a nomogram, was highly accurate, with an area under the curve value of up to 0.948, meaning it can reliably help doctors assess which patients are at greater risk of complications. Who this helps: This helps patients undergoing surgery and their doctors by identifying potential healing issues early.

Plain English
This study looked at the impact of a specific type of anesthesia called transversus abdominis plane (TAP) blocks on patients undergoing breast reconstruction using tissue from their abdomen. Researchers analyzed data from 256 patients and found that those who received TAP blocks used significantly less pain medication and stayed in the hospital for shorter periods compared to those who didn't receive TAP blocks. For example, patients with TAP blocks had an average hospital stay of 2.71 days, compared to 3.62 days for those without a TAP block, and they used 113.69 milligrams of morphine on average, compared to 195.55 milligrams for those without the block. Who this helps: This helps breast reconstruction patients by potentially leading to quicker recoveries and reduced pain medication needs.

Plain English
This study looked at how sickle cell trait (SCT) affects pregnancy and newborn health by comparing outcomes between pregnant women with SCT and those without. Researchers found that women with SCT had a slightly higher chance of developing urinary tract infections or kidney infections (12% vs. 7%) and a lower chance of having low birth weight babies (10% vs. 16%). This is important because while SCT does not increase the risk of high blood pressure during pregnancy, it does highlight a greater risk for infections and a protective effect against low birth weight. Who this helps: This information benefits pregnant women with sickle cell trait and their healthcare providers.

Plain English
This study looked at a new treatment called autologous tumor-infiltrating lymphocyte (TIL) cell therapy for patients with advanced head and neck cancer that had come back after other treatments. Of the 53 patients treated, 11% (6 patients) had some tumor shrinkage, and 76% (40 patients) had stable disease that did not progress for a period of time. These findings are important because they show that TIL therapy can be safely used and may provide some benefit for patients whose cancer has not responded to traditional treatments. Who this helps: This helps patients with recurrent and advanced head and neck cancer.

Plain English
This study looked at how different healthcare professionals can work together to improve medication use for older patients. They focused on a patient who wanted to return to volunteering but was struggling with unsteadiness and low energy due to her medications. The team made adjustments to her medications using specific guidelines, which helped her feel better and more capable of achieving her goals. Who this helps: This helps older patients who are struggling with medication side effects and want to improve their daily lives.

Plain English
This study looked at how being male or female and being obese affects the chances of liver cancer coming back and survival rates in pancreatic cancer patients who had surgery. Researchers found that among nearly 1,000 patients, women with obesity had the best outcomes, with only a 13% chance of liver cancer returning after one year and surviving for a median of 37 months. This matters because it highlights the importance of considering sex and weight in treatment plans for better patient outcomes. Who this helps: This helps doctors and patients with pancreatic cancer, especially women with obesity.

Plain English
Researchers studied a new type of treatment for bladder cancer by focusing on a protein called NECTIN4, which is important for attacking cancer cells. They found that a drug known as rosiglitazone boosts NECTIN4 levels in cancer cells, helping a specialized immune therapy called CAR T cell therapy work better, especially against tough-to-treat tumors that have become resistant to other drugs. This is significant because it opens up new possibilities for treating patients whose cancer doesn’t respond to existing therapies. Who this helps: This helps bladder cancer patients, particularly those with tumors resistant to standard treatments.

Plain English
This study explored how exposure to a specific bacteria, S. aureus, affects food allergies in patients with a skin condition called atopic dermatitis (AD). Researchers found that patients with S. aureus on their skin had higher levels of a substance called interleukin-4 (IL-4), which is linked to food allergies. In a mouse study, applying the bacteria along with food allergens led to a stronger allergic response and higher IL-4 levels, pointing to a potential pathway that worsens food allergies in these patients. Who this helps: This benefits patients with atopic dermatitis and food allergies.

Plain English
This study examined how climate change affects grain production in China, Japan, and South Korea, focusing on rice, wheat, and maize. Researchers found that climate conditions greatly influence crop yields; for instance, rice production in northern China is expected to rise while southern areas may see a decrease of over 30%. Wheat production is likely to drop by about 10% in total, but impacts in Japan and South Korea will be minimal, with changes under 2.5%. Who this helps: This information benefits farmers and agricultural planners in East Asia.

Plain English
This study looked at blood cells called T follicular helper cells in 153 children with various immune diseases, specifically immune thrombocytopenia (ITP), warm autoimmune hemolytic anemia (wAIHA), and Evans Syndrome (ES). Researchers found that higher levels of these cells (above 9.5%) were effective at distinguishing ES from ITP and wAIHA, with an accuracy of 76% for identifying those with ES. This finding is important because it could help doctors better diagnose and monitor these conditions, as well as identify patients who need additional testing for immune-related issues. Who this helps: Patients with immune cytopenias and their doctors.

Plain English
This study looked at patients who received a HeartMate 3 device to help their heart pump but developed serious early heart complications requiring additional support. Researchers compared two approaches: using a right ventricular assist device (RVAD) right away during the initial surgery versus waiting until complications arose. They found that the upfront method (U-RVAD) resulted in fewer complications, with 31% of these patients dying within 90 days compared to 68% of those who received RVAD later, significantly improving their chances of survival. Who this helps: This information benefits heart failure patients needing mechanical support and their doctors, as it helps guide treatment decisions.

Plain English
This study looked at how to predict the risk of heart failure or heart muscle disease in women undergoing treatment for breast cancer. Researchers found that, among over 26,000 women, the risk of developing these heart issues in the next ten years was about 1.7% for those at low risk and 19.4% for those at high risk, depending on various health factors and treatment types. This matters because it helps doctors identify women who need closer heart monitoring and preventive care after breast cancer treatment. Who this helps: This helps breast cancer patients and their healthcare providers.

Plain English
This study looked at how a specific gene called PTGES3 affects the androgen receptor (AR), which plays a key role in advanced prostate cancer. Researchers found that when PTGES3 was reduced, the levels of AR decreased, leading to halted cell growth and death of cancer cells. This is important because cancer patients whose tumors resist current treatments might benefit from targeting PTGES3 to enhance the effectiveness of existing therapies. Who this helps: Patients with advanced prostate cancer who struggle with treatment resistance.

Plain English
This study investigated the relationship between a protein called IL-18Rα and severe respiratory viral diseases like influenza, COVID-19, and RSV in patients. It found that patients with life-threatening cases had significantly higher levels of IL-18Rα on certain immune cells (CD8 T cells), which were also linked to reduced ability to kill infected cells. Specifically, there was an increased severity in disease for mice with high IL-18Rα levels, suggesting this protein could help identify those at risk for severe infections. Who this helps: This helps doctors identify patients who might develop severe respiratory viral diseases.

Plain English
This study looked at how genes interact in human cells, especially in relation to cancer, by using new techniques. Researchers found hundreds of new genetic interactions that could be important for cancer treatments, including a strong focus on proteins that help with cell sugar processes. These findings improve our understanding of genetic relationships in cancer, making it easier to find potential new therapies. Who this helps: This benefits researchers and doctors developing cancer treatments.

Plain English
The POLAR trial studied the effects of a combination therapy (pembrolizumab and olaparib) on 63 patients with advanced pancreatic cancer who had already shown some response to chemotherapy. The results showed that while the targeted treatment did not meet the main goals for Cohort A (where patients had specific genetic mutations), it did reveal that 56% of patients were alive after two years, and some markers in the blood indicated potential for better outcomes in patients with certain tumor characteristics. This matters because it highlights the importance of customizing cancer treatments based on individual genetic factors, which may lead to better patient outcomes. Who this helps: This helps patients with metastatic pancreatic cancer and their healthcare providers.